In pancreatic cancer, m6A stimulates the PI3K/Akt/mTOR pathway, driving cancer cell proliferation (105, 106), whereas m1A and m5C are linked with activation of the mTOR pathway and unfavorable prognoses (107, 108). This evidence concerns the gene MTOR and familial pancreatic carcinoma.